Product Information
OXTELLAR XR 300 MG TABLET is a brand product labeled by Supernus Pharmaceuticals Inc., priced at $12.7546 per EA under NDC 17772012201. Its NADAC has been published 654 times since Dec 18, 2013.
The High Outlier badge above means this manufacturer's average price in the OXCARBAZEPINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Supernus Pharmaceuticals Inc.NDC
17772012201
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXCARBAZEPINEApproval Type
New Drug (NDA)
FDA Application
NDA202810On Market Since
1/17/2013
Pharmacological Classes
Price Statistics
The NADAC for OXTELLAR XR 300 MG TABLET has been published 654 times since Dec 18, 2013, and over the history we have for it it has risen 215.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.7546 per EA |
|---|---|
| All-time high | $12.7554 (Aug 13, 2025) |
| All-time low | $4.0446 (Dec 18, 2013) |
| 52-week high | $12.7554 |
| 52-week low | $12.6923 |
| Median price | $9.5045 |
| Average price | $9.0964 |
| Largest weekly change | +13.9% (Jul 23, 2014) |
| Weeks tracked | 654 |
| Tracking since | Dec 18, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXTELLAR XR 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXTELLAR XR 300 MG TABLET, manufactured by Supernus Pharmaceuticals Inc., is $12.7546 per EA (NDC 17772012201), effective Jun 24, 2026.
How has the price of OXTELLAR XR 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXTELLAR XR 300 MG TABLET has risen 215.3%. It has been tracked across 654 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for OXTELLAR XR 300 MG TABLET?
Since Dec 18, 2013, the NADAC for OXTELLAR XR 300 MG TABLET has ranged from a low of $4.0446 (Dec 18, 2013) to a high of $12.7554 (Aug 13, 2025), with a median of $9.5045 per EA.
Are there cheaper alternatives to OXTELLAR XR 300 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OXCARBAZEPINE 300 MG TABLET, is $0.1664 per EA — about 99% below OXTELLAR XR 300 MG TABLET.
Who manufactures OXTELLAR XR 300 MG TABLET?
OXTELLAR XR 300 MG TABLET (NDC 17772012201) is labeled by Supernus Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification